Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $2.09 billion. The enterprise value is $1.77 billion.
| Market Cap | 2.09B |
| Enterprise Value | 1.77B |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 35.98 million shares outstanding. The number of shares has increased by 16.66% in one year.
| Shares Outstanding | 35.98M |
| Shares Change (YoY) | +16.66% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 6.36% |
| Owned by Institutions (%) | 88.57% |
| Float | 26.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13,799.68 |
| Forward PS | n/a |
| PB Ratio | 6.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11,694.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.25, with a Debt / Equity ratio of 0.04.
| Current Ratio | 14.25 |
| Quick Ratio | 13.64 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.70% and return on invested capital (ROIC) is -49.02%.
| Return on Equity (ROE) | -46.70% |
| Return on Assets (ROA) | -42.60% |
| Return on Capital (ROIC) | -49.02% |
| Revenue Per Employee | $1,110 |
| Profits Per Employee | -$1.12M |
| Employee Count | 136 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.55% in the last 52 weeks. The beta is 1.27, so KROS's price volatility has been higher than the market average.
| Beta (1Y) | 1.27 |
| 52-Week Price Change | +23.55% |
| 50-Day Moving Average | 63.46 |
| 200-Day Moving Average | 44.25 |
| Relative Strength Index (RSI) | 33.43 |
| Average Volume (30 Days) | 371,587 |
Short Selling Information
The latest short interest is 2.26 million, so 6.27% of the outstanding shares have been sold short.
| Short Interest | 2.26M |
| Short Previous Month | 2.10M |
| Short % of Shares Out | 6.27% |
| Short % of Float | 8.65% |
| Short Ratio (days to cover) | 6.49 |
Income Statement
In the last 12 months, KROS had revenue of $151,000 and -$152.99 million in losses. Loss per share was -$5.20.
| Revenue | 151,000 |
| Gross Profit | 151,000 |
| Operating Income | -169.94M |
| Pretax Income | -152.99M |
| Net Income | -152.99M |
| EBITDA | -150.63M |
| EBIT | -152.99M |
| Loss Per Share | -$5.20 |
Balance Sheet
The company has $332.36 million in cash and $14.44 million in debt, giving a net cash position of $317.92 million or $8.84 per share.
| Cash & Cash Equivalents | 332.36M |
| Total Debt | 14.44M |
| Net Cash | 317.92M |
| Net Cash Per Share | $8.84 |
| Equity / Book Value | 332.21M |
| Book Value Per Share | 9.23 |
| Working Capital | 322.92M |
Cash Flow
In the last 12 months, operating cash flow was -$124.51 million and capital expenditures -$2.46 million, giving a free cash flow of -$126.97 million.
| Operating Cash Flow | -124.51M |
| Capital Expenditures | -2.46M |
| Free Cash Flow | -126.97M |
| FCF Per Share | -$4.31 |
Margins
Gross margin is 100.00%, with operating and profit margins of -112,543.71% and -101,319.21%.
| Gross Margin | 100.00% |
| Operating Margin | -112,543.71% |
| Pretax Margin | -101,319.21% |
| Profit Margin | -101,319.21% |
| EBITDA Margin | -99,751.66% |
| EBIT Margin | -101,319.21% |
| FCF Margin | -84,087.42% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.66% |
| Shareholder Yield | -16.66% |
| Earnings Yield | -7.34% |
| FCF Yield | -6.09% |
Analyst Forecast
The average price target for KROS is $86.00, which is 48.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $86.00 |
| Price Target Difference | 48.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 398.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 31.31 and a Piotroski F-Score of 1.
| Altman Z-Score | 31.31 |
| Piotroski F-Score | 1 |